MS-DRG 918

Principal Diagnosis - Pdx

• T45.621A Poisoning by hemostatic drug, accidental (unintentional), initial encounter
• T45.622A Poisoning by hemostatic drug, intentional self-harm, initial encounter
• T45.623A Poisoning by hemostatic drug, assault, initial encounter
• T45.624A Poisoning by hemostatic drug, undetermined, initial encounter
• T45.625A Adverse effect of hemostatic drug, initial encounter
• T45.691A Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
• T45.692A Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
• T45.693A Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter
• T45.694A Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
• T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
• T45.7X1A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
• T45.7X2A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
• T45.7X3A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
• T45.7X4A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
• T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
• T45.8X1A Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
• T45.8X2A Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
• T45.8X3A Poisoning by other primarily systemic and hematological agents, assault, initial encounter
• T45.8X4A Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter
• T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
• T45.91XA Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
• T45.92XA Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
• T45.93XA Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
• T45.94XA Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
• T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
• T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
• T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
• T46.0X3A Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
• T46.0X4A Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
• T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
• T46.1X1A Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
• T46.1X2A Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
• T46.1X3A Poisoning by calcium-channel blockers, assault, initial encounter
• T46.1X4A Poisoning by calcium-channel blockers, undetermined, initial encounter
• T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
• T46.2X1A Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
• T46.2X2A Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
• T46.2X3A Poisoning by other antidysrhythmic drugs, assault, initial encounter
• T46.2X4A Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
• T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
• T46.3X1A Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
• T46.3X2A Poisoning by coronary vasodilators, intentional self-harm, initial encounter
• T46.3X3A Poisoning by coronary vasodilators, assault, initial encounter
• T46.3X4A Poisoning by coronary vasodilators, undetermined, initial encounter
• T46.3X5A Adverse effect of coronary vasodilators, initial encounter
• T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
• T46.4X2A Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
• T46.4X3A Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
• T46.4X4A Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
• T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
• T46.5X1A Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
• T46.5X2A Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
• T46.5X3A Poisoning by other antihypertensive drugs, assault, initial encounter
• T46.5X4A Poisoning by other antihypertensive drugs, undetermined, initial encounter
• T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter
• T46.6X1A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
• T46.6X2A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
• T46.6X3A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
• T46.6X4A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
• T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
• T46.7X1A Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
• T46.7X2A Poisoning by peripheral vasodilators, intentional self-harm, initial encounter
• T46.7X3A Poisoning by peripheral vasodilators, assault, initial encounter
• T46.7X4A Poisoning by peripheral vasodilators, undetermined, initial encounter
• T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
• T46.8X1A Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
• T46.8X2A Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
• T46.8X3A Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
• T46.8X4A Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
• T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
• T46.901A Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
• T46.902A Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
• T46.903A Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
• T46.904A Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
• T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
• T46.991A Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
• T46.992A Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
• T46.993A Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
• T46.994A Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
• T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
• T47.0X1A Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
• T47.0X2A Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
• T47.0X3A Poisoning by histamine H2-receptor blockers, assault, initial encounter
• T47.0X4A Poisoning by histamine H2-receptor blockers, undetermined, initial encounter
• T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
• T47.1X1A Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
• T47.1X2A Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
• T47.1X3A Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
• T47.1X4A Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
• T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
• T47.2X1A Poisoning by stimulant laxatives, accidental (unintentional), initial encounter
• T47.2X2A Poisoning by stimulant laxatives, intentional self-harm, initial encounter
• T47.2X3A Poisoning by stimulant laxatives, assault, initial encounter
• T47.2X4A Poisoning by stimulant laxatives, undetermined, initial encounter
• T47.2X5A Adverse effect of stimulant laxatives, initial encounter
• T47.3X1A Poisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
• T47.3X2A Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
• T47.3X3A Poisoning by saline and osmotic laxatives, assault, initial encounter
• T47.3X4A Poisoning by saline and osmotic laxatives, undetermined, initial encounter
• T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter